Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: chest pain, dyspnea on exertion major surgical or invasive procedure: coronary artery bypass graft x 4(lima->lad, svg->rca, om) history of present illness: 60 y/o male adm. to osh w/cp, found to have elev. troponin and pulmonary edema. transferred to for cardiac catheterization. past medical history: congestive heart failure, diabetes mellitus, hypertension, chronic renal insufficiency newly started on hemodialysis , anemia, fournier's gangrene s/p scrotal surgery, s/p appendectomy and tonsillectomy social history: retired, smoked x 30 years, quit 5 years ago, rare etoh family history: non-contrib. physical exam: vs: 87 20 155/66 5'0" 84kg general: well-appearing w/ sob heent: ncat, eomi, perrl neck: supple, from -jvd chest: ctab -w/r/r heart: rrr -c/r/m/g abd: soft nt/nd, +bs ext: warm, well-perfused with 1 +edema, -varicosities neuro: mae, non-focal, a&o x 3 pertinent results: cath : selective coronary angiography of this right dominant system demonstrated severe 3 vessel disease. the lmca was short but normal. the lad was subtotally occluded after s1, remainder of the lad was small with diffuse irregularities filling antegrade and via rca acute marginal collaterals. the lcx had diffuse disease and the om2 was occluded and filled via collaterals. the rca was occluded at mid vessel after the acute marginal which filled the distal lad. there was mild pulmonary hypertension with pap 40/16 mmhg). left ventriculography revealed severe global hypokinesis with lvef 29%. no significant mitral regurgitation was evident. cnis : bilateral less than 40% carotid stenosis. likely left subclavian stenosis. chest ct : moderate emphysema. widespread interstitial pulmonary abnormality including fibrosis and interstitial pneumonitis, consistent with ipf. echo : prebypass: the left atrium is moderately dilated. there is mild symmetric left ventricular hypertrophy. the left ventricular cavity is mildly dilated. there is moderate regional left ventricular systolic dysfunction with lvef 30-40%. resting regional wall motion abnormalities include septal hypokinesis at the base, septal akinesis from mid basal region to apex, inferior wall hypokinesis at the base and inferior wall akinesis at the apex. a prominent thrombus is seen in the left ventricle, adherent to the ventricular wall near the apex. there are simple atheroma in the aortic arch. there are complex (mobile) atheroma in the descending aorta. there is no aortic valve stenosis. no aortic regurgitation is seen. trivial mitral regurgitation is seen. post bypass: no new regional wall motion or valvular abnormalities observed. lvef 30-40%. no new aortic abnormalities observed. cxr : right ij line is unchanged with tip in the right atrium. compared to , there has been no significant change in the lower lobe volume loss, prominent interstitial markings versus scarring in the left lateral lung, mild cardiomegaly. 10:55am blood wbc-8.5 rbc-4.10* hgb-12.3* hct-36.2* mcv-88 mch-30.1 mchc-34.0 rdw-15.6* plt ct-170 04:34am blood wbc-6.9 rbc-1.69* hgb-4.9* hct-14.4* mcv-85 mch-28.8 mchc-33.8 rdw-16.9* plt ct-205 08:15am blood wbc-6.3 rbc-3.55* hgb-10.6* hct-32.1* mcv-90 mch-29.7 mchc-32.9 rdw-16.6* plt ct-247 02:46pm blood pt-16.6* inr(pt)-1.5* 06:25am blood pt-30.1* inr(pt)-3.2* 01:23pm blood pt-70.2* ptt-45.4* inr(pt)-9.0* 10:15am blood pt-19.5* ptt-30.2 inr(pt)-1.9* 02:46pm blood glucose-149* urean-37* creat-3.2* na-142 k-3.7 cl-106 hco3-22 angap-18 08:40am blood glucose-135* urean-47* creat-4.7* na-134 k-4.3 cl-99 hco3-27 angap-12 08:15am blood glucose-174* urean-21* creat-3.6* na-140 k-3.9 cl-99 hco3-32 angap-13 08:15am blood calcium-7.4* phos-3.7 mg-1.5* 05:46am urine blood-sm nitrite-neg protein-30 glucose-neg ketone-neg bilirub-neg urobiln-neg ph-5.0 leuks-neg 08:23pm urine rbc-* wbc- bacteri-mod yeast-none epi- brief hospital course: pt. was admitted to the medical service, medical management was optimized, he received regular hemodialysis treatments, and was taken to the or on with dr. . he underwent a cabg x 4 (lima > lad, svg>diag>om, svg>pda). please see operative note for details of surgical procedure. pt. was transported to the cardiac surgical recovery unit for invasive monitoring in stable condition. later on op day he was weaned from sedation, awoke neurologically intact and was extubated. his epicardial wires and chest tubes were removed on pod # 1, and warfarin was initiated(due to finding of lv thrombus in the or). he remained hemodynamically stable and was transferred to the telemetry unit on pod # 2. he continued on regular dialysis, was being anticoagulated, and had remained stable until early am on . at that time, he had a bloody bm, was lightheaded, and diaphoretic. he was transferred to the icu. his inr which had been in the 3's had rapidly increased to 6, then to 9 just prior to this incident. his hematocrit dropped to the mid-teens. he was transfused rbc's & plasma, received vitamin k. gi was consulted, and he underwent ugi endoscopy (on )which showed gastritis (not actively bleeding). egd was repeated on which showed gastritis & duodenitis. he remained hemodynamically stable after his anticoagulation was reversed, and he was again transferred to the telemetry floor. he underwent a colonoscopy on , which revealed polyps, and normal mucosa. anticoagulation was again initiated (for post-op af, as well as the lv thrombus noted in the or) with warfarin and iv heparin was given while waiting for the inr to become therapeutic. on , he was noted to have some bleeding in his left eye, ophthalmalogy was consulted (pt. has long-standing history of retinopathy, prev. vitreous hemmorhage, legally blind). he was found to have vitreous hemmorhage, and eye drops were initiated as recommended. his eye was patched, and anticoagulation was stopped. throughout post-op course he received regular hemodialysis treatments and worked with physical therapy for strength and mobility. he appeared stable and suitable for discharge home on post-op day 20. he was not restarted on coumadin seoncadry to the his sensitivity and bleeding complications. he was discharged home with vna services and the appropriate follow-up appointments. medications on admission: toprol 50 mg po daily, glyburide 1.25 mg po daily, norvasc 20 mg po daily, albuterol, doxazosin 2 mg po daily, nephrocaps, asa 325 mg po daily, plavix 75 mg po daily, lasix 20 mg po daily discharge medications: 1. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*2* 2. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 3. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets po every 6-8 hours as needed for pain. disp:*50 tablet(s)* refills:*0* 4. atorvastatin 10 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 5. b complex-vitamin c-folic acid 1 mg capsule sig: one (1) cap po daily (daily). disp:*30 cap(s)* refills:*2* 6. calcium carbonate 500 mg tablet, chewable sig: one (1) tablet, chewable po tid (3 times a day). disp:*90 tablet, chewable(s)* refills:*2* 7. norvasc 10 mg tablet sig: one (1) tablet po once a day. disp:*30 tablet(s)* refills:*2* 8. protonix 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po once a day. disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 9. b complex-vitamin c-folic acid 1 mg capsule sig: one (1) cap po daily (daily). disp:*30 cap(s)* refills:*2* 10. scopolamine hbr 0.25 % drops sig: one (1) drop ophthalmic (2 times a day). disp:*1 vial* refills:*2* 11. prednisolone acetate 1 % drops, suspension sig: one (1) drop ophthalmic qid (4 times a day). disp:*1 vial* refills:*2* 12. amiodarone 200 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 13. metoprolol tartrate 25 mg tablet sig: three (3) tablet po tid (3 times a day). disp:*270 tablet(s)* refills:*2* 14. doxazosin 1 mg tablet sig: two (2) tablet po hs (at bedtime). disp:*30 tablet(s)* refills:*2* 15. enalapril maleate 10 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 16. dorzolamide-timolol 2-0.5 % drops sig: one (1) drop ophthalmic (2 times a day). disp:*1 vial* refills:*2* 17. glyburide 1.25 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* discharge disposition: home with service facility: home health and hospice care, discharge diagnosis: coronary artery disease s/p coronary artery bypass graft x 4 pmh: congestive heart failure, diabetes mellitus, hypertension, chronic renal insufficiency newly started on hemodialysis , anemia, fournier's gangrene s/p scrotal surgery, s/p appendectomy and tonsillectomy discharge condition: good discharge instructions: follow medications on discharge instructions. do not drive for 4 weeks. do not lift more than 10 lbs. for 2 months. shower daily, let water flow over wounds, pat dry with a towel. do not use creams, powders, or lotions on wounds. call our office with sternal drainage, temp>101.5 followup instructions: make an appointment with dr. for 1-2 weeks. make an appointment with dr. for 4 weeks. procedure: (aorto)coronary bypass of three coronary arteries single internal mammary-coronary artery bypass extracorporeal circulation auxiliary to open heart surgery combined right and left heart cardiac catheterization coronary arteriography using two catheters angiocardiography of left heart structures other endoscopy of small intestine diagnostic ultrasound of heart hemodialysis colonoscopy endoscopic control of gastric or duodenal bleeding transfusion of packed cells transfusion of other serum infusion of vasopressor agent diagnoses: hyperpotassemia anemia in chronic kidney disease end stage renal disease abnormal coagulation profile coronary atherosclerosis of native coronary artery congestive heart failure, unspecified acute posthemorrhagic anemia acute kidney failure, unspecified atrial fibrillation systolic heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease disorders of phosphorus metabolism postinflammatory pulmonary fibrosis acute myocardial infarction of unspecified site, initial episode of care benign neoplasm of colon legal blindness, as defined in u.s.a. hypotension of hemodialysis duodenitis, with hemorrhage other specified gastritis, without mention of hemorrhage diabetes with renal manifestations, type ii or unspecified type, uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled proliferative diabetic retinopathy vitreous hemorrhage 

Answer: The patient is high likely exposed to